Sun Zhong-ji, Zhang Jian-ming, Wang Hui, Liu Jun-ping
Department of Emergency, Affiliated Hospital of Chinese People Force Police Army's Medical College, Tianjin 300162, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Aug;19(8):485-7.
To sum up the experience of treating patients suffering from organophosphorous pesticide poisoning either through skin or through gastrointestinal tract.
The cholinesterase activity was less than 0.50 in all patients. They were divided into two groups: poisoning through skin (skin group) and by gastrointestinal route (gastrointestinal group). The number of poisoning through skin or gastrointestinal tract was 34 (19 cases of middle degree and 15 cases of severe degree) and 50 (22 cases of middle degree and 28 cases of severe degree), respectively. The blood cholinesterase activities were determined during the disease course, the clinical symptoms and signs were recorded, and the quantity of atropine used for treatment in respective group was also recorded.
There were no difference in the cholinesterase activities at the same degree between two groups before treatment (P>0.05). But the symptoms of the patients in gastrointestinal group were more serious than in skin group. The cholinesterase activities of the patients in the skin group were higher significantly than that in the gastrointestinal group at 24, 48 and 72 hours after treatment (P<0.05 or P<0.01). The total amount of atropine to achieve atropinization was less in the skin group than that of the gastrointestinal group. The time for restoration of cholinesterase activity was shorter in skin group than the gastrointestinal group (both P<0.01).
With the same level of enzymatic activity of cholinesterase, the symptoms of the patients poisoned via gastrointestinal tract are more serious than poisoning through skin, and the quantity of atropine is used very much more. Reactivation of the cholinesterase is earlier in patients poisoned by skin route.
总结经皮肤和经胃肠道途径有机磷农药中毒患者的治疗经验。
所有患者胆碱酯酶活性均低于0.50。将患者分为两组:经皮肤中毒组(皮肤组)和经胃肠道中毒组(胃肠道组)。经皮肤或胃肠道中毒的人数分别为34例(中度19例,重度15例)和50例(中度22例,重度28例)。在病程中测定血液胆碱酯酶活性,记录临床症状和体征,并记录各组治疗所用阿托品的量。
两组治疗前相同程度时胆碱酯酶活性无差异(P>0.05)。但胃肠道组患者症状比皮肤组更严重。治疗后24、48和72小时皮肤组患者胆碱酯酶活性显著高于胃肠道组(P<0.05或P<0.01)。皮肤组达到阿托品化的阿托品总量少于胃肠道组。皮肤组胆碱酯酶活性恢复时间短于胃肠道组(均P<0.01)。
在胆碱酯酶酶活性水平相同的情况下,经胃肠道中毒患者的症状比经皮肤中毒更严重,且阿托品用量更多。经皮肤途径中毒患者胆碱酯酶的复能更早。